These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24450160)

  • 21. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
    Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma].
    Pronina IV; Klimov EA; Burdennyy AM; Beresneva EV; Fridman MV; Ermilova VD; Kazubskaya TP; Karpukhin AV; Braga EA; Loginov VI
    Mol Biol (Mosk); 2017; 51(1):73-84. PubMed ID: 28251969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
    Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
    Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
    Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
    Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S
    Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
    Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
    Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
    Wang J; Yu XF; OUYang N; Luo Q; Tong J; Chen T; Li J
    J Toxicol Environ Health A; 2019; 82(17):935-943. PubMed ID: 31524549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
    Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
    Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.
    Gao L; Cheng D; Yang J; Wu R; Li W; Kong AN
    J Nutr Biochem; 2018 Jun; 56():109-115. PubMed ID: 29525530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
    Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
    Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation regulated microRNAs in human cervical cancer.
    Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
    Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.